Related Experiment Video
Updated: Jan 16, 2026

MAME Models for 4D Live-cell Imaging of Tumor: Microenvironment Interactions that Impact Malignant Progression
Published on: February 17, 2012
Membrane glycoprotein nectin-4 in tumor associated pathways and anti-cancer therapeutics
Namrata Ganguli1, Sarbartha Mukherjee1, Dibyendu Samanta1
1Department of Bioscience and Biotechnology, Indian Institute of Technology Kharagpur, Kharagpur, 721302, West Bengal, India.
Abstract:
Nectin-4, a cell adhesion molecule (CAM) of the immunoglobulin superfamily of proteins, has recently gained prominence as a tumor-associated antigen. Although, primarily considered as a cell adhesion glycoprotein involved in embryonic development, its enhanced expression in various types of cancers and its negligible presence in healthy adult tissues makes it a potent target for developing anti-cancer therapeutics. Moreover, the extracellular portion of nectin-4 is shed off by the action of matrix metalloproteinases, which leads to its presence in the blood of cancer patients, thereby making it a serological cancer marker that can be targeted for diagnostic purposes. This review discusses the role of nectin-4 in several pathophysiological aspects of cancer progression by linking these to the molecular mechanistic details of cell-signaling pathways. Moreover, it also provides very intricate categorical documentation and analysis of the expression pattern of nectin-4 in various forms of cancer. It further emphasizes on the therapeutic approaches targeting nectin-4, thus depicting the importance of this protein in basic and clinical cancer research. This review also extends its scope of discussion beyond cancer biology by presenting the involvement of nectin-4 in embryonic development and infectious diseases to provide a holistic significance of this protein in human health and diseases.
Insights
Nectin-4, a tumor antigen, is highly expressed in cancers but not healthy tissues, making it a promising target for cancer diagnostics and therapeutics. Its role extends to embryonic development and infectious diseases.
Area of Science:
- Oncology
- Molecular Biology
- Immunology
Background:
- Nectin-4 is a cell adhesion molecule (CAM) belonging to the immunoglobulin superfamily.
- It is increasingly recognized as a tumor-associated antigen with significant implications in cancer biology.
- Nectin-4 plays roles in embryonic development and infectious diseases, indicating broader biological relevance.
Purpose of the Study:
- To review the multifaceted role of nectin-4 in cancer progression.
- To analyze the expression patterns of nectin-4 across various cancer types.
- To highlight therapeutic strategies targeting nectin-4 and its diagnostic potential.
Main Methods:
- Literature review focusing on nectin-4's role in cancer.
- Analysis of molecular mechanisms and cell-signaling pathways involving nectin-4.
- Categorical documentation and analysis of nectin-4 expression data in cancer.
Main Results:
- Nectin-4 exhibits enhanced expression in various cancers, contrasting with its minimal presence in healthy adult tissues.
- The extracellular domain of nectin-4 is shed, enabling its use as a serological cancer marker.
- Nectin-4 is implicated in cancer progression through various pathophysiological aspects and cell-signaling pathways.
Conclusions:
- Nectin-4 is a crucial target for developing novel anti-cancer therapeutics and diagnostic tools.
- Understanding nectin-4's molecular mechanisms is vital for advancing cancer research.
- Nectin-4's involvement in embryonic development and infectious diseases underscores its holistic significance in human health.
More Related Videos
Related Concept Videos
Metastasis
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Mitogens and the Cell Cycle
Non-Canonical Wnt Signaling Pathways
The Tumor Microenvironment
Targeted Cancer Therapies
There are several types of targeted therapies against...
Canonical Wnt Signaling Pathway

